Latest Merck Stories
Providers get a comprehensive view of the vaccination rate of their entire patient population through one screen within Practice Fusion's web-based electronic health record (EHR) platform SAN
SINGAPORE, April 28, 2014 /PRNewswire/ -- Moleac, a revenue-generating Biopharma company focused on stroke recovery, announced today the appointment of Mr Elmar Schnee as non-executive
ROCKLAND, Mass., April 25, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that new data from the company's multiple sclerosis (MS) portfolio
Stage and Screen Star Shines a Spotlight on Better Blood Sugar Management With America's Diabetes Challenge: Get to Your Goals Program WHITEHOUSE STATION, N.J., April 23, 2014 /PRNewswire/
BOSTON, April 17, 2014 /PRNewswire/ -- Columbia Laboratories, Inc.
Full-featured smartphone versions of popular app for doctors to include free access to The Merck Manual READING, Mass., April 16, 2014 /PRNewswire/ --
MONROVIA, Calif., April 10, 2014 /PRNewswire/ -- Xencor, Inc.
ROCKLAND, Massachusetts, April 7, 2014 /PRNewswire/ -- - First patient dosed in tecemotide Phase III trial; study recruiting
ROCKLAND, Mass., April 1, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the launch of the 10(th) edition of the EMD Serono Specialty
- Agreement aims to identify biomarkers relevant to future therapies in the area of Systemic Lupus Erythematosus and Lupus Nephritis ROCKLAND, Mass., April 1, 2014 /PRNewswire/
- A poem in which the author retracts something said in an earlier poem.